Hina Patel

915 total citations
30 papers, 466 citations indexed

About

Hina Patel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Hina Patel has authored 30 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Epidemiology. Recurrent topics in Hina Patel's work include Cancer Immunotherapy and Biomarkers (11 papers), Colorectal Cancer Treatments and Studies (6 papers) and Lung Cancer Treatments and Mutations (4 papers). Hina Patel is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Colorectal Cancer Treatments and Studies (6 papers) and Lung Cancer Treatments and Mutations (4 papers). Hina Patel collaborates with scholars based in United States, Italy and France. Hina Patel's co-authors include Denis Moro‐Sibilot, Helen Winter, Manuel Cobo, Rong Zhang, René Bruno, Jin Y. Jin, Marcin Kowanetz, Sandhya Girish, Benjamin Wu and Kari M. Morrissey and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Developmental Biology.

In The Last Decade

Hina Patel

27 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hina Patel United States 11 326 183 87 58 38 30 466
Yan-Ping Mao China 2 364 1.1× 125 0.7× 94 1.1× 52 0.9× 6 0.2× 2 417
Alyx Rosen United States 12 274 0.8× 70 0.4× 43 0.5× 38 0.7× 27 0.7× 19 507
Ricardo Fernandes Canada 12 402 1.2× 171 0.9× 75 0.9× 60 1.0× 19 0.5× 34 531
Gary W. Jean United States 7 239 0.7× 92 0.5× 80 0.9× 56 1.0× 18 0.5× 14 375
Hirotaka Ono Japan 8 449 1.4× 264 1.4× 100 1.1× 56 1.0× 42 1.1× 23 601
Mitchell S. von Itzstein United States 11 222 0.7× 101 0.6× 60 0.7× 40 0.7× 6 0.2× 32 344
Hiroshi Takita United States 9 103 0.3× 282 1.5× 61 0.7× 143 2.5× 18 0.5× 10 530
Naoya Satake Japan 12 69 0.2× 169 0.9× 38 0.4× 163 2.8× 18 0.5× 31 366
Angélique Da Silva France 7 451 1.4× 176 1.0× 86 1.0× 47 0.8× 8 0.2× 19 580
C. Rodríguez Rodríguez Spain 8 464 1.4× 191 1.0× 96 1.1× 56 1.0× 47 1.2× 15 641

Countries citing papers authored by Hina Patel

Since Specialization
Citations

This map shows the geographic impact of Hina Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hina Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hina Patel more than expected).

Fields of papers citing papers by Hina Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hina Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hina Patel. The network helps show where Hina Patel may publish in the future.

Co-authorship network of co-authors of Hina Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Hina Patel. A scholar is included among the top collaborators of Hina Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hina Patel. Hina Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Butler, Marcus O., Ryan Weight, Rizwan Haq, et al.. (2024). 1139TiP IDE196 (darovasertib) in combination with crizotinib versus investigator’s choice of treatment as first-line therapy in HLA-A2 negative metastatic uveal melanoma. Annals of Oncology. 35. S747–S747. 2 indexed citations
5.
6.
Patel, Hina, Thanh G.N. Ton, Simon Fear, et al.. (2021). Effectiveness of Additional Risk Minimization Measures for Atezolizumab in the European Union. Pharmaceutical Medicine. 35(6). 339–351.
7.
Ardizzoni, Andrea, Sérgio Jobim Azevedo, Belén Rubio‐Viqueira, et al.. (2021). Primary results from TAIL: a global single-arm safety study of atezolizumab monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer. Journal for ImmunoTherapy of Cancer. 9(3). e001865–e001865. 34 indexed citations
8.
Neep, T. J., et al.. (2020). Longitudinal impact of a pre‐populated default quantity on emergency department opioid prescriptions. SHILAP Revista de lepidopterología. 2(1). e12337–e12337. 8 indexed citations
9.
Jassem, Jacek, Roy S. Herbst, Filippo de Marinis, et al.. (2020). IMpower110: Clinical safety in a phase III study of atezolizumab (atezo) monotherapy (mono) vs platinum-based chemotherapy (chemo) in first-line non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 38(15_suppl). e21623–e21623. 11 indexed citations
10.
Morrissey, Kari M., Mathilde Marchand, Hina Patel, et al.. (2019). Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting. Cancer Chemotherapy and Pharmacology. 84(6). 1257–1267. 62 indexed citations
11.
12.
Patel, Hina, et al.. (2018). Know the name: acute epiploic appendagitis—CT findings and review of literature. AME Case Reports. 2. 8–8. 14 indexed citations
13.
Pawel, Joachim von, Rodolfo Bordoni, Miyako Satouchi, et al.. (2018). Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study. European Journal of Cancer. 107. 124–132. 79 indexed citations
14.
Carroll, Ty B, William Peppard, Bradley R. Javorsky, et al.. (2018). Continuous Etomidate Infusion for the Management of Severe Cushing Syndrome: Validation of a Standard Protocol. Journal of the Endocrine Society. 3(1). 1–12. 39 indexed citations
15.
Cortinovis, Diego, Joachim von Pawel, K. Syrigos, et al.. (2017). Immune-related adverse events (irAEs) in advanced NSCLC patients treated with atezolizumab: Safety population analyses from the Ph III study OAK. Annals of Oncology. 28. v468–v468. 4 indexed citations
16.
Patel, Hina, et al.. (2017). A need for standardization in visual acuity measurement. Arquivos Brasileiros de Oftalmologia. 80(5). 332–337. 8 indexed citations
17.
Patel, Hina, et al.. (2016). The X factor: Lack of bleeding after an acute apixaban overdose. The American Journal of Emergency Medicine. 35(5). 801.e5–801.e6. 10 indexed citations
18.
Patel, Hina, et al.. (2015). Wingless mediated apoptosis: How cone cells direct the death of peripheral ommatidia in the developing Drosophila eye. Developmental Biology. 407(2). 183–194. 8 indexed citations
19.
Patel, Hina, et al.. (2015). Collaborative screen casting in anatomy: Assessing attitudes and perception of educational resources made in partnership with medical students. Bristol Research (University of Bristol). 2 indexed citations
20.
Thompson, Dennis F., et al.. (1992). Is There a Role for Fluconazole in the Treatment of Vulvovaginal Candidiasis?. Annals of Pharmacotherapy. 26(3). 350–353. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan-Ping Mao Breakdown of academic impact, for papers by Alyx Rosen Breakdown of academic impact, for papers by Ricardo Fernandes Breakdown of academic impact, for papers by Gary W. Jean Breakdown of academic impact, for papers by Hirotaka Ono Breakdown of academic impact, for papers by Mitchell S. von Itzstein Breakdown of academic impact, for papers by Hiroshi Takita Breakdown of academic impact, for papers by Naoya Satake Breakdown of academic impact, for papers by Angélique Da Silva Breakdown of academic impact, for papers by C. Rodríguez Rodríguez
Rankless by CCL
2026